menu
    • menu

    Company profile for Lineage Cell Therapeutics

    NEW Drugs in Dev: 8
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lineage’s programs are based on the Company’s proprietary cell-based therapy platform and associated development and manufacturing capabilities. With our platform we develop and manufacture specialized, terminally-differentiated human cells from our pluripotent and progenitor cell starting materials. These differentiated cells are developed either to replace or support cells that are dysfunctional or absent due to degenera...
    Lineage’s programs are based on the Company’s proprietary cell-based therapy platform and associated development and manufacturing capabilities. With our platform we develop and manufacture specialized, terminally-differentiated human cells from our pluripotent and progenitor cell starting materials. These differentiated cells are developed either to replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury, or administered as a means of helping the body mount an effective immune response to cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lineage Cell TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2173 Salk Avenue, Suite 200 Carlsbad, CA 92008
    Telephone
    Telephone
    510-871-4188
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://lineagecell.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lineage Receives Hypoimmune Gene-Edited Cell Line From Factor Bio
    Lineage Receives Hypoimmune Gene-Edited Cell Line From Factor Bio

    06 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106778477/en/Lineage-Takes-Delivery-of-Gene-edited-Hypoimmune-Cell-Line-Under-Partnership-With-Factor-Bioscience

    BUSINESSWIRE
    06 Jan 2026
    Share Share
    Lineage Cell Therapeutics Issues Letter To Stockholders
    Lineage Cell Therapeutics Issues Letter To Stockholders

    05 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260105645057/en/Lineage-Cell-Therapeutics-Issues-Letter-to-Stockholders

    BUSINESSWIRE
    05 Jan 2026
    Share Share
    Lineage Cell Therapeutics Unveils Q3 2025 Financials
    Lineage Cell Therapeutics Unveils Q3 2025 Financials

    06 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251106230045/en/Lineage-Cell-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update

    BUSINESSWIRE
    06 Nov 2025
    Share Share
    Lineage Cell Therapeutics To Release Q3 2025 Financials Result
    Lineage Cell Therapeutics To Release Q3 2025 Financials Result

    30 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251030250805/en/Lineage-Cell-Therapeutics-to-Report-Third-Quarter-2025-Financial-Results-and-Provide-Business-Update-on-November-6-2025

    BUSINESSWIRE
    30 Oct 2025
    Share Share
    Lineage Initiates Cell Transplant Program for Type 1 Diabetes
    Lineage Initiates Cell Transplant Program for Type 1 Diabetes

    08 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-08/lineage-cell-therapeutics-initiates-cell-transplant-program-in-type-1-diabetes

    PHARMAWEB
    08 Sep 2025
    Share Share
    Lineage Cell Therapeutics to Present at Investor Conferences
    Lineage Cell Therapeutics to Present at Investor Conferences

    02 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-02/lineage-cell-therapeutics-to-present-at-september-2025-investor-conferences

    PHARMAWEB
    02 Sep 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search